While many researchers see the study results as an important step forward, many clinical physicians who treat patients with Alzheimer’s Disease remain skeptical about the drug’s real-world benefits and worried about its side effects.
Subscribe to:
Post Comments (Atom)
< + > Buy or Sell: Medical AI Assistant Edition – Healthcare IT Today Podcast Episode 170
For the 170th episode of the Healthcare IT Today Podcast , we are doing another round of Buy or Sell! For these episodes, we select a health...
-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
-
The following is a guest article by Ladd Wiley, Senior Vice President for Global Corporate Affairs, Public Policy, and Advocacy at Epic , ...
-
Training artificial intelligence models on more diverse image and data sets can augment decision making, overcome knowledge gaps, and promot...
No comments:
Post a Comment